Quarterly Results • Search Archive
Shilpa Medicare Limited
Results, Financials & Updates
Follow Shilpa Medicare Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
1 published deep dive
1 quarter 1 sector
Company Overview
Shilpa Medicare Limited: latest results and financials
About the business in Nivata's latest coverage
Shilpa Medicare Limited operates across four primary business segments: Active Pharmaceutical Ingredients (APIs), Formulations, Contract Development and Manufacturing Organization (CDMO), and Biologics, backed by emerging divisions such as Novel Drug Delivery Systems (NDDS), Antibody-Drug Conjugates (ADCs), and Recombinant Human Albumin. The company maintains a worldwide footprint spanning over 50 countries, supported by more than 10 regulatory-approved manufacturing and R&D facilities, including an analytical lab, housing over 400 R&D personnel and accumulating more than 500 regulatory filings globally.
Quarter history
Shilpa Medicare Limited Results & Financials
Latest Nivata coverage: Q1 FY27 · revenue ₹465.78 Cr · PAT ₹100.88 Cr.
Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.